Skip to content

Clinical trials

Phase 2 Idiopathic Pulmonary Fibrosis trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Idiopathic Pulmonary Fibrosis Phase: Phase 2 Country / region: Canada Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20111
20121
20133
20152
20161
20172
20191
20203
20211
20222
20233
20246
20253
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated10
Recruiting6
Active, not recruiting5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim4
Avalyn Pharma Inc.2
Celgene2
Endeavor Biomedicines, Inc.2
Hoffmann-La Roche2
Pliant Therapeutics, Inc.2
AbbVie1
Actelion1
Amgen1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Idiopathic Pulmonary Fibrosis36
Pulmonary Fibrosis11
Fibrosis5
Lung Diseases, Interstitial5
Idiopathic Interstitial Pneumonias3
Cough1
Lung Diseases1
Pathologic Processes1
Respiratory Tract Diseases1

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.